/Companies

Vistara

5 known investors

Find your way into Vistara

Sign up to see every warm intro you have to Vistara

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Vistara team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

VistaraBio provides research tools and services for drug discovery, including modified protein assays, post-translationally modified protein catalogs, and cell screening platforms using bioactive peptides. The company serves pharmaceutical and biotech researchers developing small molecule and protein degrader therapeutics.

Founders & leadership

GNGirish Nallur, PhD CLP
Girish Nallur, PhD CLPFounderGirish Nallur holds a PhD and has built expertise in protein post-translational modifications, molecular interactions in drug discovery (including work on cereblon substrates and protein degraders), and proteomics. He founded VistaraBio to develop research tools and platforms for drug discovery, including assays and bioactive peptide-based screening systems.

Investors · 5

Frequently asked questions

What does Vistara do?
VistaraBio provides research tools and services for drug discovery, including modified protein assays, post-translationally modified protein catalogs, and cell screening platforms using bioactive peptides. The company serves pharmaceutical and biotech researchers developing small molecule and protein degrader therapeutics.
Who founded Vistara?
Vistara was founded by Girish Nallur, PhD CLP.
Who are Vistara's investors?
Vistara's investors include Connecticut Innovations, Armitage Associates, Integrity Growth Partners, Plymouth Growth, Vistara Growth.